Loading clinical trials...
Loading clinical trials...
The purpose of this academic lead study is to explore the effect of noninvasive neuromodulation of the CM-pf via tTIS for patients with disorders of consciousness.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Xijing Hospital
NCT06797752 · OCTA, Severe Brain Injury, and more
NCT06939348 · Consciousness Disorders, Disorders of Consciousness Due to Severe Brain Injury
NCT06323031 · Disorders of Consciousness
NCT06871800 · Stroke, Vascular Severe Brain Injury, and more
NCT06157008 · Disorders of Consciousness
Xijing Hospital
Xi'an, Shaanxi
Xijing Hospital
Xi'an, Shaanxi
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions